Anti-CA15.3 and Anti-CA125 Antibodies and Ovarian Cancer Risk: Results from the EPIC Cohort. (2018)

First Author: Cramer DW

Attributed to: The EPIC-Norfolk prospective population study: biological and behavioural determinants of health and disease in an ageing population funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/1055-9965.epi-17-0744

PubMed Identifier: 29661801

Publication URI: http://europepmc.org/abstract/MED/29661801

Type: Journal Article/Review

Volume: 27

Parent Publication: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Issue: 7

ISSN: 1055-9965